• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子受体 7 通过激活整合素 αvβ3 促进头颈部转移性鳞状细胞癌中的细胞迁移和黏附。

Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3.

机构信息

Department of Oromaxillofacial-Head and Neck Surgery, School of Stomatology, China Medical University, Heping District, Shenyang, Liaoning 110002, PR China.

出版信息

Int J Mol Med. 2011 May;27(5):679-87. doi: 10.3892/ijmm.2011.628. Epub 2011 Feb 23.

DOI:10.3892/ijmm.2011.628
PMID:21347514
Abstract

The mechanisms leading to squamous cell carcinoma of the head and neck (SCCHN) metastasis are incompletely understood. Although evidence shows that the chemokine receptor 7 (CCR7) and its ligand CCL19 may regulate tumor dissemination, their role in SCCHN is not clearly defined. CCR7 has been shown to regulate integrins, which facilitate adhesion of cancer cells to and/or migration through the extracellular matrix (ECM). To investigate the relationship between CCR7 and integrin αvβ3 in metastatic SCCHN, we used adhesion and migration assays, immunofluorescence staining and western blotting to determine whether integrin αvβ3 can be activated by CCL19 in the metastatic SCCHN cell line PCI-37B, which was pre-incubated with CCL19 or the integrin αvβ3 inhibitor, IS201. Our results demonstrate that CCR7 favors PCI-37B cell adhesion and migration, induces reorganization of the actin cytoskeleton and induces integrin αvβ3 phosphorylation. The integrin αvβ3 inhibitor, IS201, blocked all of these effects. CCR7 and integrin αvβ3 expression significantly and positively correlated with tumor size, clinical stage and nodal metastasis. Taken together, our data indicate that CCR7 regulates cell adhesion and migration via integrin αvβ3 in metastatic SCCHN. These results should provide the groundwork for new strategies aimed at preventing SCCHN metastasis.

摘要

导致头颈部鳞状细胞癌 (SCCHN) 转移的机制尚不完全清楚。尽管有证据表明趋化因子受体 7 (CCR7) 及其配体 CCL19 可能调节肿瘤扩散,但它们在 SCCHN 中的作用尚不清楚。已经表明 CCR7 调节整合素,整合素促进癌细胞与细胞外基质 (ECM) 的黏附和/或迁移。为了研究 CCR7 与转移性 SCCHN 中整合素 αvβ3 之间的关系,我们使用黏附和迁移测定、免疫荧光染色和 Western blot 来确定整合素 αvβ3 是否可以被 CCL19 激活在预先用 CCL19 或整合素 αvβ3 抑制剂 IS201 孵育的转移性 SCCHN 细胞系 PCI-37B 中。我们的结果表明,CCR7 有利于 PCI-37B 细胞的黏附和迁移,诱导肌动蛋白细胞骨架的重排,并诱导整合素 αvβ3 磷酸化。整合素 αvβ3 抑制剂 IS201 阻断了所有这些作用。CCR7 和整合素 αvβ3 的表达与肿瘤大小、临床分期和淋巴结转移显著正相关。综上所述,我们的数据表明 CCR7 通过整合素 αvβ3 调节转移性 SCCHN 中的细胞黏附和迁移。这些结果应为旨在预防 SCCHN 转移的新策略提供基础。

相似文献

1
Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3.趋化因子受体 7 通过激活整合素 αvβ3 促进头颈部转移性鳞状细胞癌中的细胞迁移和黏附。
Int J Mol Med. 2011 May;27(5):679-87. doi: 10.3892/ijmm.2011.628. Epub 2011 Feb 23.
2
The chemokine receptor 7 regulates cell adhesion and migration via beta1 integrin in metastatic squamous cell carcinoma of the head and neck.趋化因子受体 7 通过β1 整合素调节头颈部转移性鳞状细胞癌中的细胞黏附和迁移。
Oncol Rep. 2010 Oct;24(4):989-95. doi: 10.3892/or.2010.989.
3
Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.趋化因子受体7通过激活基质金属蛋白酶-9增强头颈部转移性鳞状细胞癌的细胞趋化性和迁移能力。
Oncol Rep. 2014 Aug;32(2):794-800. doi: 10.3892/or.2014.3242. Epub 2014 Jun 6.
4
CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck.CCL19 诱导的趋化因子受体 7 通过 Cdc42 激活磷酯酰肌醇-3 激酶介导的侵袭通路在头颈部转移性鳞状细胞癌中。
Oncol Rep. 2011 Mar;25(3):729-37. doi: 10.3892/or.2010.1109. Epub 2010 Dec 14.
5
Chemokine receptor 7 promotes tumor migration and invasiveness via the RhoA/ROCK pathway in metastatic squamous cell carcinoma of the head and neck.趋化因子受体7通过RhoA/ROCK信号通路促进头颈部转移性鳞状细胞癌的肿瘤迁移和侵袭。
Oncol Rep. 2015 Feb;33(2):849-55. doi: 10.3892/or.2014.3631. Epub 2014 Nov 27.
6
[Expression of integrin αvβ3, CXC chemokine receptor 4 and CXC chemokine receptor 7 and their relationship with lymph node metastasis in squamous cell carcinoma of head and neck].整合素αvβ3、CXC趋化因子受体4和CXC趋化因子受体7的表达及其与头颈部鳞状细胞癌淋巴结转移的关系
Zhonghua Kou Qiang Yi Xue Za Zhi. 2017 Dec 9;52(12):723-729. doi: 10.3760/cma.j.issn.1002-0098.2017.12.003.
7
RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.RGD与整合素αvβ3的结合影响原发性人乳腺癌培养物中的细胞运动性和粘附。
Ultrastruct Pathol. 2012 Dec;36(6):387-99. doi: 10.3109/01913123.2012.681834. Epub 2012 Nov 26.
8
CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck.CCR7 通过 MAPKs 调控头颈部转移性鳞状细胞癌中的细胞迁移和侵袭。
Int J Oncol. 2014 Dec;45(6):2502-10. doi: 10.3892/ijo.2014.2674. Epub 2014 Sep 25.
9
Chemokine receptor 7 via proline-rich tyrosine kinase-2 upregulates the chemotaxis and migration ability of squamous cell carcinoma of the head and neck.趋化因子受体 7 通过富含脯氨酸的酪氨酸激酶-2 上调头颈部鳞状细胞癌的趋化性和迁移能力。
Oncol Rep. 2012 Nov;28(5):1659-64. doi: 10.3892/or.2012.1989. Epub 2012 Aug 23.
10
Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.头颈癌中自分泌和旁分泌趋化因子受体7激活:对治疗的意义
J Natl Cancer Inst. 2008 Apr 2;100(7):502-12. doi: 10.1093/jnci/djn059. Epub 2008 Mar 25.

引用本文的文献

1
[Assessment of baseline CCL19 dendritic cell infiltration for predicting responses to immunotherapy in lung adenocarcinoma patients].[评估基线CCL19树突状细胞浸润以预测肺腺癌患者对免疫治疗的反应]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Aug 20;44(8):1529-1536. doi: 10.12122/j.issn.1673-4254.2024.08.11.
2
Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology.单细胞 RNA 测序技术分析 CCR7 对小鼠口腔鳞状细胞癌微环境的影响。
J Exp Clin Cancer Res. 2024 Mar 27;43(1):94. doi: 10.1186/s13046-024-03013-y.
3
C-C Chemokine Receptor 7 in Cancer.
C-C 趋化因子受体 7 在癌症中的作用。
Cells. 2022 Feb 14;11(4):656. doi: 10.3390/cells11040656.
4
Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications.癌症治疗中的修饰间充质干细胞:一种需要升级以实现更广泛临床应用的智能武器。
World J Stem Cells. 2022 Jan 26;14(1):54-75. doi: 10.4252/wjsc.v14.i1.54.
5
Does CCL19 act as a double-edged sword in cancer development?CCL19 是否在癌症发展中充当双刃剑?
Clin Exp Immunol. 2022 Apr 4;207(2):164-175. doi: 10.1093/cei/uxab039.
6
HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.HPV 感染相关免疫浸润基因与 HNSCC 的治疗策略和临床结局相关。
BMC Cancer. 2020 Aug 24;20(1):796. doi: 10.1186/s12885-020-07298-y.
7
[Stromal cell-derived factor-1 inducing metastasis squamous cell carcinoma of head and neck induced via integrin ανβ3-CXC chemokine receptor 4/7 biological axis].[基质细胞衍生因子-1通过整合素ανβ3-CXC趋化因子受体4/7生物轴诱导头颈部鳞状细胞癌转移]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2018 Aug 1;36(4):398-403. doi: 10.7518/hxkq.2018.04.010.
8
RGD-Binding Integrins in Head and Neck Cancers.头颈部癌症中的RGD结合整合素
Cancers (Basel). 2017 May 26;9(6):56. doi: 10.3390/cancers9060056.
9
CC-chemokine receptor 7 and its ligand CCL19 promote mitral valve interstitial cell migration and repair.C-C趋化因子受体7及其配体CCL19促进二尖瓣间质细胞迁移和修复。
J Biomed Res. 2015 Nov;29(6):456-64. doi: 10.7555/JBR.29.20150031. Epub 2015 Sep 9.
10
Association of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinoma.趋化因子及趋化因子受体表达与肺癌侵袭和转移的关联
Oncol Lett. 2015 Sep;10(3):1315-1322. doi: 10.3892/ol.2015.3402. Epub 2015 Jun 22.